Resveratrol treatment attenuates chemokine receptor expression in the BTBR T + tf/J mouse model of autism

Molecular and Cellular Neuroscience

Volumn 77, Issue , 2016, Pages 1-10

  Bakheet, Saleh A ^a   Alzahrani, Mohammad Zeed ^a   Nadeem, Ahmed ^a   Ansari, Mushtaq Ahmad ^a   Zoheir, Khairy M A ^a,b   Attia, Sabry M ^a,c   AL Ayadhi, Laila Yousef ^d   Ahmad, Sheikh Fayaz ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c Al Azhar University   (Egypt)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Autism; Brain; BTBR T + tf J; C57BL 6J; CCR and CXCR; Resveratrol; Spleen

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; MESSENGER RNA; RESVERATROL; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BRAIN; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG TARGETING; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTISTIC DISORDER; BRAIN; CELLS, CULTURED; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE; RNA, MESSENGER; SPLEEN; STILBENES;

EID: 84990847896     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2016.09.004     Document Type: Article

References (61)

1. Ahmad, S.F., Zoheir, K.M., Bakheet, S.A., Ashour, A.E., Attia, S.M., Attia poly(ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model. Cytokine 68:2014 (2014), 76–85.
2. Ahmad, S.F., Zoheir, K.M., Ansari, M.A., Korashy, H.M., Bakheet, S.A., Ashour, A.E., Attia, S.M., Stimulation of the histamine 4 receptor with 4-methylhistamine modulates the effects of chronic stress on the Th1/Th2 cytokine balance. Immunobiology 220:3 (2015), 341–349.
3. Ahmad, S.F., Zoheir, K.M., Ansari, M.A., Nadeem, A., Bakheet, S.A., Al-Hoshani, A.R., Al-Shabanah, O.A., Al-Harbi, M.M., Attia, S.M., Histamine 4 receptor promotes expression of costimulatory B7.1/B7.2 molecules, CD28 signaling and cytokine production in stress-induced immune responses. J. Neuroimmunol. 15:289 (2015), 30–42.
4. Albani, D., Polito, L., Signorini, A., Forloni, G., Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36:5 (2010), 370–376.
5. Andjelkovic, A.V., Kerkovich, D., Shanley, J., Pulliam, L., Pachter, J.S., Expression of binding sites for chemokines on human astrocytes. Glia, 28, 1999, 225.
6. Ashwood, P., Enstrom, A., Krakowiak, P., Hertz-Picciotto, I., Hansen, R.L., Croen, L.A., Ozonoff, S., Pessah, I.N., Van de Water, J., Decreased transforming growth factor β1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J. Neuroimmunol. 204:1–2 (2008), 149–153.
7. Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I.N., Van de Water, J., Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J. Neuroimmunol. 232:1–2 (2011), 196–199.
8. Axtell, R.C., Steinman, L., Gaining entry to an uninflamed brain. Nat. Immunol. 10:5 (2009), 453–455.
9. Babcock, A., Owens, T., Chemokines in experimental autoimmune encephalomyelitis and multiple sclerosis. Adv. Exp. Med. Biol. 520 (2003), 120–132.
10. Bagaeva, L.V., Rao, P., Powers, J.M., Segal, B.M., CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J. Immunol. 176:12 (2006), 7676–7685.
11. Bajetto, A., Bonavia, R., Barbero, S., Schettini, G., Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 82 (2002), 1311–1329.
12. Bakheet, S.A., Attia, S.M., Alwetaid, M.Y., Ansari, M.A., Zoheir, K.M., Nadeem, A., Al-Shabanah, O.A., Al-Harbi, M.M., Ahmad, S.F., β-1,3-Glucan reverses aflatoxin B1-mediated suppression of immune responses in mice. Life Sci. 1:152 (2016), 1–13.
13. Bakheet, S.A., Alzahrani, M.Z., Ansari, M.A., Nadeem, A., Zoheir, K.M., Attia, S.M., Al-Ayadhi, L.Y., Ahmad, S.F., Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in a BTBR T + tf/J Mouse Model of Autism. Mol. Neurobiol., 2016 Aug. 30. (Epub ahead of print).
14. Balashov, K.E., Rottman, J.B., Weiner, H.L., Hancock, W.W., CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 6873–6878.
15. Bambini-Junior, V., Zanatta, G., Della Flora Nunes, G., Mueller de Melo, G., Michels, M., Fontes-Dutra, M., Nogueira Freire, V., Riesgo, R., Gottfried, C., Resveratrol prevents social deficits in animal model of autism induced by valproic acid. Neurosci. Lett. 583 (2014), 176–181.
16. Biber, K., Dijkstra, I., Trebst, C., De Groot, C.J., Ransohoff, R.M., Boddeke, H.W., Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia. Neuroscience 112 (2002), 487–497.
17. Biber, K., de Jong, E.K., van Weering, H.R., Boddeke, H.W., Chemokines and their receptors in central nervous system disease. Curr. Drug Targets 7 (2006), 29–46.
18. Blanchard, D.C., Defensor, E.B., Meyza, K.Z., Pobbe, R.L., Pearson, B.L., Bolivar, V.J., Blanchard, R.J., BTBR Tþtf/J mice: autism-relevant behaviors and reduced fractone-associated heparan sulfate. Neurosci. Biobehav. Rev., 36(10), 2012, 2370.
19. Boyd, A.B., McDonough, G.S., Bodfish, W.J., Evidence-based behavioral interventions for repetitive behaviors in autism. J. Autism Dev. Disord. 42:6 (2012), 1236–1248.
20. Chevallier, C., Kohls, G., Troiani, V., Brodkin, E.S., Schultz, R.T., The social motivation theory of autism. Trends Cogn. Sci., 16, 2012, 231e239.
21. Constantino, J.N., The quantitative nature of autistic social impairment. Pediatr. Res., 69, 2011, 55Re62R.
22. Engelhardt, B., Ransohoff, R.M., Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 33:12 (2012), 579–589.
23. Enstrom, A., Onore, C., Van de Water, J., Ashwood, P., Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav. Immun. 24:1 (2010), 64–71.
24. Flynn, G., Maru, S., Loughlin, J., Romero, I.A., Male, D., Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 136 (2003), 84–93.
25. Frith, C.D., Frith, U., Mechanisms of social cognition. Annu. Rev. Psychol., 63, 2012, 287e313.
26. Garbett, K., Ebert, P.J., Mitchell, A., Lintas, C., Manzi, B., Mirnics, K., Persico, A.M., Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol. Dis. 30:3 (2008), 303–311.
27. Ho, D.J., Calingasan, N.Y., Wille, E., Dumont, M., Beal, M.F., Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease. Exp. Neurol. 225:1 (2010), 74–84.
28. Holman, D.W., Klein, R.S., Ransohoff, R.M., The blood-brain barrier, chemokines and multiple sclerosis. Biochim. Biophys. Acta 1812:2 (2011), 220–230.
29. Hong, J.H., Lee, H., Lee, S.R., Protective effect of resveratrol against neuronal damage following transient global cerebral ischemia in mice., 27, 2016, 146–152.
30. Jin, F., Wu, Q., Lu, Y.F., Gong, Q.H., Shi, J.S., Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur. J. Pharmacol. 600:1–3 (2008), 78–82.
31. Karpus, W.J., Fife, B.T., Kennedy, K.J., Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease. Methods 29 (2003), 362–368.
32. Kivisäkk, P., Trebst, C., Liu, Z., Tucky, B.H., Sørensen, T.L., Rudick, R.A., Mack, M., Ransohoff, R.M., T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking. Clin. Exp. Immunol. 129:3 (2002), 510–518.
33. Kivisakk, P., Mahad, D.J., Callahan, M.K., et al. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann. Neurol. 55 (2004), 627–638.
34. Kizil, C., Dudczig, S., Kyritsis, N., Machate, A., Blaesche, J., Kroehne, V., Brand, M., The chemokine receptor cxcr5 regulates the regenerative neurogenesis response in the adult zebrafish brain. Neural Dev., 23(7), 2012, 27.
35. Kogan, M.D., Blumberg, S.J., Schieve, L.A., Boyle, C.A., Perrin, J.M., Ghandour, R.M., Singh, G.K., Strickland, B.B., Trevathan, E., van Dyck, P.C., Prevalence of parentreported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics 124:5 (2009), 1395–1403.
36. Leonard, S.S., Xia, C., Jiang, B.H., Stinefelt, B., Klandorf, H., Harris, G.K., Shi, X., Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 309:4 (2003), 1017–1026.
37. Li, X., Chauhan, A., Sheikh, A.M., Patil, S., Chauhan, V., Li, X.M., Ji, L., Brown, T., Malik, M., Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 207:1–2 (2009), 111–116.
38. Li, L., Zhi, D., Shen, Y., Liu, K., Li, H., Chen, J., Effects of CC-chemokine receptor 5 on ROCK2 and P-MLC2 expression after focal cerebral ischaemia-reperfusion injury in rats. Brain Inj. 30:4 (2016), 468–473.
39. Lombardo, M.V., Baron-Cohen, S., The role of the self in mind blindness in autism. Conscious. Cogn., 20, 2011, 130e140.
40. Louboutin, J.P., Chekmasova, A., Marusich, E., Agrawal, L., Strayer, D.S., Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage. FASEB J. 25 (2011), 737–753.
41. McFarlane, H.G., Kusek, G.K., Yang, M., Phoenix, J.L., Bolivar, V.J., Crawley, J.N., Autism-like behavioral phenotypes in BTBR Tþtf/J mice. Genes Brain Behav. 7 (2008), 152–163.
42. Moriya, J., Chen, R., Yamakawa, J., Sasaki, K., Ishigaki, Y., Takahashi, T., Resveratrol improves hippocampal atrophy in chronic fatigue mice by enhancing neurogenesis and inhibiting apoptosis of granular cells. Biol. Pharm. Bull. 34:3 (2011), 354–359.
43. Olaussen, R.W., Karlsson, M.R., Lundin, K.E., Jahnsen, J., Brandtzaeg, P., Farstad, I.N., Reduced chemokine receptor 9 on intraepithelial lymphocytes in celiac disease suggests persistent epithelial activation. Gastroenterology 132 (2007), 2371–2382.
44. Pang, C., Cao, L., Wu, F., Wang, L., Wang, G., Yu, Y., Zhang, M., et al. The effect of trans-resveratrol on post-stroke depression via regulation of hypothalamus-pituitary-adrenal axis. Neuropharmacology 97 (2015), 447–456.
45. Papadakis, K.A., Prehn, J., Moreno, S.T., Cheng, L., Kouroumalis, E.A., Deem, R., Breaverman, T., et al. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology 121 (2001), 246–254.
46. Reichel, C.A., Khandoga, A., Anders, H.J., Schlondorff, D., Luckow, B., Krombach, F., Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue. J. Leukoc. Biol. 79 (2006), 114–122.
47. Rutz, H.L., Rothblat, L.A., Intact and impaired executive abilities in the BTBR mouse model of autism. Behav. Brain Res. 234:1 (2012), 33–37.
48. Scattoni, M.L., Gandhy, S.U., Ricceri, L., Crawley, J.N., Unusual repertoire of vocalizations in the BTBR T + tf/J mouse model of autism. PLoS One, 3(8), 2008, e3067.
49. Sha, H., Ma, Q., Jha, R.K., Xu, F., Wang, L., Wang, Z., Zhao, Y., Fan, F., Resveratrol ameliorates hepatic injury via the mitochondrial pathway in rats with severe acute pancreatitis. Eur. J. Pharmacol. 601:1–3 (2008), 136–142.
50. Silverman, J.L., Tolu, S.S., Barkan, C.L., Crawley, J.N., Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 35 (2010), 976–989.
51. Soleas, G.J., Diamandis, E.P., Goldberg, D.M., The world of resveratrol. Adv. Exp. Med. Biol. 492 (2001), 159–182.
52. Sørensen, T.L., Trebst, C., Kivisäkk, P., Klaege, K.L., Majmudar, A., Ravid, R., Lassmann, H., Olsen, D.B., Strieter, R.M., Ransohoff, R.M., Sellebjerg, F., Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system. J. Neuroimmunol. 127 (2002), 59–68.
53. Unsoeld, H., Voehringer, D., Krautwald, S., Pircher, H., Constitutive expression of CCR7 directs effector CD8 T cells into the splenic white pulp and impairs functional activity. J. Immunol. 173 (2004), 3013–3019.
54. Van der Meer, P., Ulrich, A.M., Gonzalez-Scarano, F., Lavi, E., Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp. Mol. Pathol. 69 (2000), 192–201.
55. Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W., Pardo, C.A., Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57:1 (2005), 67–81.
56. Villablanca, E.J., Cassani, B., von Andrian, U.H., Mora, J.R., Blocking lymphocyte localization to the gastrointestinal mucosa as a therapeutic strategy for inflammatory bowel diseases. Gastroenterology 140:6 (2011), 1776–1784.
57. Wainwright, D.A., Xin, J., Mesnard, N.A., Beahrs, T.R., Politis, C.M., Sanders, V.M., Jones, K.J., Exacerbation of facial motoneuron loss after facial nerve axotomy in CCR3-deficient mice. ASN Neuro, 1, 2009, e00024.
58. Wang, B., Sun, J., Li, X., Zhou, Q., Bai, J., Shi, Y., Le, G., Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity. Nutr. Res. 33:11 (2013), 971–981.
59. Westmoreland, S.V., Rottman, J.B., Williams, K.C., Lackner, A.A., Sasseville, V.G., Chemokine receptor expression on resident and inflammatory cells in the brains of macaques with simian immunodeficiency virus encephalitis. Am. J. Pathol. 152 (1998), 659–665.
60. + T cells in the brain and visualization of a kinesis-associated system of reticular fibers. Immunity 30:2 (2009), 300–311.
61. Zhang, F., Liu, J., Shi, J.S., Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur. J. Pharmacol. 636:1–3 (2010), 1–7.